In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects
Sunday, June 3, 2012 - 00:10
in Health & Medicine
Known as T-DM1, the drug delayed the progression of cancer by three months in a late-stage clinical trial of 991 women with metastatic breast cancer.